MannKind Corporation Reports 2021 First Quarter Financial Results
12 mai 2021 16h00 HE
|
MannKind
Conference Call to Begin Today at 5:00 PM ET 1Q 2021 Total Revenues of $17.4 million; +7% vs. 1Q 2020Received $230.0 million gross proceeds from 2.5% senior convertible notes$278.3 million of Cash,...
MannKind Corporation to Participate in 2021 RBC Capital Markets Global Healthcare Conference
11 mai 2021 09h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021
05 mai 2021 09h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 first quarter financial results and its management will host a conference call to...
MannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche
26 avr. 2021 09h00 HE
|
MannKind
Paid Off Mann Group Non-Convertible Note of $35.1 Million in Principal plus $4.4 Million in Accrued InterestPrepaid $10.0 Million Owed Under MidCap Credit Facility and Increased Borrowings Available...
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
19 avr. 2021 06h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., April 19, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the...
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes
16 mars 2021 09h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that on March 15, 2021 it issued an additional $30.0 million aggregate principal...
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors
15 mars 2021 08h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that it will participate in the 2022 Medicare Part D Senior Savings Model, which is...
MannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference
10 mars 2021 17h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference
02 mars 2021 17h00 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering
02 mars 2021 06h30 HE
|
MannKind
WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the pricing of $200.0 million aggregate principal amount of 2.50% Convertible Senior...